Partner at FLG Partners | Chief Financial Officer CFO | Interim CFO for Growth Stage + Enterprise Companies | Finance, Accounting, Audit, Systems, Financial Software, Management | M&A, Capital Fundraising | Board Advisor
With the challenging macro economic reality we are all wondering how the capital markets will look in the next 12 months. Many Biotech companies are evaluating the potential value of an IPO at their next value inflection point. These companies need to be poised to move quickly towards an IPO if the markets turn favorable. Get my FLG Partners partner, Nancy Hargreaves' take on how Life Sciences players need to take the right steps to prepare for this moment: https://lnkd.in/gkHzhivn #iporeadiness #goingpublic #flgpartners
